AstraZeneca: Bid could create 'enormous disruption'

The chief executive of AstraZeneca, Pascal Soriot, has told ITV News Business Editor Joel Hills that the takeover bid from Pfizer could create "enormous disruption" to his firm.

Read: Pfizer and AstraZeneca give evidence at select committee


Ed Miliband: 'Serious concerns' over proposed Pfizer deal

Following a brief 30 minute with Pfizer chief executive Ian Read after today's hearing Mr Miliband said: "There are serious concerns about this proposed takeover. There are too many unanswered questions about British science and British industry".